Results 41 to 50 of about 202 (68)

Geographic atrophy and factors associated with disease progression among Medicare Advantage enrollees. [PDF]

J Manag Care Spec Pharm
Saundankar V, Borns M, Broderick K, Shah B, Cowburn S, McFadden S, Suehs B.   +6 more
europepmc   +1 more source

Do Chemically Modified Oligonucleotide Therapeutics Require Environmental Risk Assessment? [PDF]

Environ Sci Technol
Hofstetter TB, Scheidat I, Mansfeldt C, Robinson SL, Sander M, Bürgmann H.   +5 more
europepmc   +1 more source

Test-Retest Repeatability of a Novel Photopic Microperimetry Approach in Patients with Geographic Atrophy. [PDF]

Ophthalmol Sci
Tandon NR, Vasquez E, Csaky KG.
europepmc   +1 more source

Gene-Agnostic Therapeutic Strategies for Inherited Retinal Diseases: Neuroprotection and Immunomodulation. [PDF]

Genes (Basel)
Rowe LW, Becerra SP, MacLaren RE, Avery RL, Wykoff CC, Ho AC, Regillo CD, Eliott D, Osborne A, Binley KM, Ciulla TA.   +10 more
europepmc   +1 more source

Aptamers in Drug Delivery Development. [PDF]

Mater Today (Kidlington)
Wen C, Wang Y, Wang Y.
europepmc   +1 more source

C3a and C5a plasma concentrations in patients with diabetic retinopathy: a cross-sectional study. [PDF]

Int J Retina Vitreous
Dias PB, Messias-Reason I, Boff GR, Hokazono K, Hokazono K, Nisihara R.   +5 more
europepmc   +1 more source

Perilesional Fundus Autofluorescence Patterns Are Not Static: Longitudinal Transitions in Geographic Atrophy and Association with Disease Progression. [PDF]

Ophthalmol Sci
Antropoli A, Vacirca F, Introini U, Bandello F, Battaglia Parodi M, Cicinelli MV.   +5 more
europepmc   +1 more source

Targeting the Eye: RNA-Based Therapies, Interferences, and Delivery Strategies. [PDF]

Pharmaceutics
Hassan MSA, Zhong C, Hassan F, Li SK.
europepmc   +1 more source

Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone Disorders. [PDF]

JACS Au
Ma Y, Amu G, Pan Y, Jiang H, Yu S, Zhang H, Chen Z, Luo H, Zhong C, Yang X, Tao X, Zhang Y, Yu Y, Lu A, Wang L, Zhang B, Zhang G.   +16 more
europepmc   +1 more source

Differences in imaging biomarkers between patients with intermediate and advanced non-neovascular age-related macular degeneration (AMD) in the University of Colorado AMD registry. [PDF]

Eur J Ophthalmol
Lisker-Cervantes A, Gill Z, Gnanaraj R, Rajeswaren V, Mehta N, Gange B, Patnaik JL, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N, de Carlo Forest TE.   +12 more
europepmc   +1 more source